top of page
EDUCATION
FOR ALL.
KNOWLEDGE IS POWER.
All4Cure believes in democratizing access to all resources and information that may be useful for those navigating cancer care. This is a comprehensive resource for understanding multiple myeloma, patients' and clinicians' journeys with All4Cure, and for updates on the latest developments in treatment and research.
Whether you're a patient, clinician, or researcher, explore All4Cure's diverse range of content across myeloma basics, clinical trial information, expert interviews, newsletters, and more to empower yourself with knowledge and connect with the myeloma community.
Featured Posts:
Search
Oncology Times - Melflufen
In a recent article published in Oncology Times, Dr. Tony Blau was interviewed along with Dr. Paul Richardson, Dr. Yvonne Efebera, and Dr. Heinz Ludwig about Melflufen (Melphalan Flufenamide). The FDA withdrew approval for Melflufen's use in relapse and refractory Multiple Myeloma in the U.S in October 2021. In contrast, the EMA (European Medicines Agency) approved the use of Melflufen in the E.U. in August 2022. To read more about what Dr. Blau, Dr. Richardson, Dr. Efebera,
Oct 271 min read
Remembering Dr. Brian G.M Durie
It's with heavy hearts that we at All4Cure announce the passing of our dear friend, Dr. Brian G.M Durie on Oct 12, 2025 at the age of 82. A message about Dr. Durie from our founder, Tony: "Through the full application of his intelligence, charm, and persuasiveness, Brian was one of the foremost contributors to the transformation of multiple myeloma from a rapidly fatal death sentence to a chronic and perhaps even curable disease. Others will more fully describe Brian’s many
Oct 171 min read
All4Cure Named 2025 Prix Galien USA Nominee for Best Digital Health Solution
We are proud to announce that All4Cure has been selected as a 2025 Prix Galien USA Nominee for Best Digital Health Solution. The Prix...
Aug 131 min read
All4Cure and Exigent Research Join Forces to Advance Cancer Care and Clinical Trials
A New Collaboration to Put Patients First and Accelerate Medical Discoveries At All4Cure, we’ve always believed that patient‑centered...
Aug 62 min read
Dr. Tara Graff
All4Cure is proud to spotlight Dr. Tara Graff , a hematologist/oncologist at Mission Cancer + Blood in Des Moines, Iowa, and a passionate...
Jul 21 min read
Abstract: Definition of High-Risk Multiple Myeloma
The International Myeloma Society (IMS) and International Myeloma Working Group (IMWG) have published an updated Consensus Recommendation...
Jun 182 min read
How to Register for All4Cure
How to Register for All4Cure Registering for All4Cure? Follow along with this step-by-step video to join our growing community of...
May 221 min read
The Successor-1 Study for relapsed or refractory multiple myeloma (RRMM)
All4Cure is providing information about clinical trial for relapsed multiple myeloma called Successor-1 Study The purpose of this study...
Mar 52 min read
The Successor-2 Study for relapsed or refractory multiple myeloma (RRMM)
All4Cure is providing information about clinical trial for relapsed multiple myeloma called Successor-2 Study The purpose of this study...
Mar 52 min read
Revolutionizing Cancer Care: All4Cure and OnCare Launch Value-Based Clinical Pathway for Newly Diagnosed Multiple Myeloma Patients
All4Cure and OnCare, a network of community oncology practices dedicated to advancing patient-centric care, have joined forces to build...
Apr 15, 20241 min read
Let's Talk About Clinical Trials and Lines of Therapy
There are two main types of clinical trials, observational and interventional studies. Observational studies seek to learn information...
Nov 23, 20213 min read
Pod4Cure #8: A Curriculum for Cancer
Pod4Cure #8 - A CURRICULUM FOR CANCER In this episode of Pod4Cure, we are joined by Cynthia Chmielewski, a myeloma patient whose work...
Nov 18, 202115 min read
Coffee with All4Cure - Josh (3/3)
As a young myeloma patient, I, and many others like me, are confronted with three big challenges. There's work, parenthood, and the...
Nov 15, 20212 min read
Coffee with All4Cure - Josh (2/3)
I was diagnosed with Multiple Myeloma about seven years ago when I was in my early 40s. I was in Beijing on a business trip, and I was...
Nov 10, 20212 min read
Coffee with All4Cure - Josh (1/3)
I've been biking for close to 20 years, and I'm a pretty avid road cyclist. I did the London to Paris myeloma ride for Myeloma UK about...
Nov 9, 20211 min read
Coffee with All4Cure - Julie (3/3)
It's interesting that I ever became involved in myeloma patient advocacy because I am a shy person. I'm not too fond of public speaking,...
Nov 3, 20212 min read
Coffee with All4Cure - Julie (2/3)
When I first started noticing something was wrong, it was around the fall of 2018 when the time changed for Daylight Savings. I noticed I...
Nov 1, 20212 min read
Newsletter - Complementary Therapies: Nature(al) versus Nurture
Complementary Therapies: Nature(al) versus Nurture A Message from Dr. Tony Blau Many myeloma patients are understandably drawn to...
Nov 1, 20214 min read
bottom of page